![Ryan Bond](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Bond
Corporate Officer/Principal chez
ACLARION, INC.
Fortune : 178 887 $ au 31/08/2026
Profil
Ryan Bond is currently Chief Strategy Officer at Aclarion, Inc., a position started in 2021.
Formerly, Mr. Bond was Director-Healthcare Solutions at NuVasive LLC from 2014 to 2018.
Mr. Bond completed undergraduate education at The Ohio University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACLARION, INC. 3,09 % | 13/08/2026 | 76 122 ( 3,09 % ) | 178 887 $ | 31/08/2026 |
Postes actifs de Ryan Bond
| Sociétés | Poste | Début |
|---|---|---|
| ACLARION, INC. | Corporate Officer/Principal | 15/09/2021 |
Anciens postes connus de Ryan Bond
| Sociétés | Poste | Fin |
|---|---|---|
| NUVASIVE, INC. | Corporate Officer/Principal | 01/09/2018 |
Formation de Ryan Bond
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
Aclarion, Inc.
 Aclarion, Inc. Packaged SoftwareTechnology Services Develops investigational software to analyze chemical makeup of intervertebral discs in spine | Technology Services |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
